Research and Markets (http://www.researchandmarkets.com/research/d72388/asia_pacific_marke) has announced the addition of the "Asia Pacific Markets for Spinal Implants 2009-2013" report to their offering.

The largest factor driving the Asia Pacific market for spinal implants is the growing adoption of spinal non-fusion technologies, which will accelerate toward the end of the forecast period as new products and technologies enter the market. The ability to maintain a physically active lifestyle is the primary benefit of using spinal non-fusion technologies because they do not restrict motion in the operated segments of the spine. Reimbursement for these treatments, however, has been severely impacted by negative decisions from the Australian government. Also, the negative impact of the economic recession, particularly in South Korea, has caused procedural growth to fall short of previous estimates. Many patients may opt out of receiving spinal non-fusion treatment if there is limited or no coverage. Additionally, there is no spinal non-fusion technology market in Japan due to the country´s stringent regulatory approval system.

Despite the rising interest in spinal non-fusion technologies, however, spinal fusion will remain the favored treatment for severe back pain because it is supported by more clinical evidence and surgeons are more familiar with fusion techniques. Nevertheless, leading companies are allocating extensive resources to obtain reimbursement for spinal non-fusion devices, and this will be a leading contributor to market growth over the forecast period. The aging population of the Asia Pacific will also drive demand for spinal implants because the likelihood of spinal pathologies such as degenerative disc disease increases with age.

Questions answered in this report:

• Unfavorable reimbursement conditions will hamper growth of the spinal non-fusion technology market in the Asia Pacific. Which spinal non-fusion technology markets will be affected through 2014 and in which countries? Will the segments impacted obtain more favorable reimbursement over the forecast period? What effect will this lack ofor limitedreimbursement have on the spinal fusion market? Are procedure volumes and average selling prices (ASPs) of both segments impacted?
• The release of new spinal non-fusion technologies and increasing competition in existing spinal non-fusion technology segments will negatively impact the spinal fusion market. How will the release of new spinal non-fusion technologies affect growth of the spinal fusion market and to what extent? What influence will the rising number of competitors in the Asia Pacific spinal non-fusion market have on the growth of this segment?
• The global economic downturn will affect spinal fusion and non-fusion procedure volumes and ASPs differently in country in the Asia Pacific. Which countries will be most impacted by the recession? Which market segments will be most severely perturbed? When are the affected markets expected to return to prerecession levels?

Scope: Regions covered: Japan, Australia, and South Korea

Segmentation: Our analysis uses the following segmentation of the market for each country except Japan, where spinal non-fusion technologies are not expected to be available over the forecast period:

Spinal fusion:

• Traditional thoracolumbar implants (degenerative, deformity, and tumor/trauma)
• Traditional cervical implants (anterior and posterior)
• Interbody devices (lumbar [anterior, lateral, posterior, and transforaminal], cervical, and corpectomy)

Spinal non-fusion:

• Interspinous process decompression devices
• Pedicle-screw based dynamic stabilization systems
• Cervical artificial discs
• Lumbar artificial discs
• Annulus repair devices
• Nuclear disc prostheses
• Facet arthroplasty devices

Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 7-year period (2007-2013).

Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.

Companies Mentioned:

• Abbott Spine (now owned by Zimmer Spine)
• Alphatec Spine
• Australian Surgical Innovations
• AustSpine
• B. Braun Aesculap
• Biomet Spine
• BK MEDITECH
• Cervitech
• DePuy Spine
• Device Technologies Australia
• Global Orthopaedic Technology
• GS Medical
• Inion Oy
• Japan Medical Dynamic Marketing
• Japan Medical Materials
• Korea Bone Bank
• LDR Spine
• Lifehealthcare
• Medtronic Spinal & Biologics
• Medyssey
• Mizuho Medical
• National Surgical Corporation
• NuVasive
• Orthotech Orthopaedic Group
• Paradigm Spine
• Peter Brehm
• Raymedica (now Centinel Spine)
• Scient´x
• Shinwoo Medical
• Showa Ika Kohgyo
• Soelim International
• Solco Biomedical
• Stryker Spine
• Surgical House
• Synthes Spine
• Taeyeon Medical
• Tokibo (distributes for Eurosurgical)
• U&I Corporation
• Yufu Itonaga
• Zimmer Spine

For more information visit http://www.researchandmarkets.com/research/d72388/asia_pacific_marke

Source: Millennium Research Group

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716